Market Cap 146.52B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 8.13
Forward PE 8.19
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 43,483,800
Avg Vol 73,203,125
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 25%
Beta 0.46
Analysts Sell
Price Target $28.32

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Tiger65
Tiger65 Dec. 10 at 5:08 AM
$PFE in COVID times this company’s drug was bought by the government and the mandate to be vaccinated has been issued by the government and administration of the USA. That‘s why this news is not eaten so hot as it has been cooked.
0 · Reply
AlertsAndNews
AlertsAndNews Dec. 10 at 4:13 AM
$MRNA $PFE $BNTX FDA Probes Potential Links Between Covid-19 Vaccines and Adult Deaths – Bloomberg The FDA has opened an investigation into whether Covid-19 vaccines may be connected to deaths in adults, federal health officials said. An HHS spokesperson noted the agency is reviewing cases across multiple age groups as part of a broader safety assessment.
0 · Reply
grocklein
grocklein Dec. 10 at 4:10 AM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 10 at 3:28 AM
Enter: $PFE Calls Strike Price: $26 Expiry Date: JAN 02 2026 Buy in Price: $0.45 - $0.45 Sell Price: $0.68 Profit : +52% (Turn every $1 into $1.52) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 2:37 AM
Actionable Trade Alert for $PFE: Market Context: $PFE is currently trading at $25.36, with an RSI of 49.06 indicating a neutral momentum. The stock is positioned between its 60D high of $27.69 and low of $23.58, suggesting potential for upward movement. Directional Bias: The price is above the 30-day moving average (MA30) of $25.11 and the 50-day moving average (MA50) of $25.19, indicating a bullish sentiment. The ATR of 0.59 suggests moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $25.40 - Stop Loss: $24.80 (approximately 2.4% risk) - Take Profit Targets: 1. $26.00 (2.35% gain) 2. $26.75 (5.43% gain) 3. $29.75 (17.45% gain) With this plan, we aim for a minimum ROI of 17% on the third target while maintaining a manageable risk. Stay informed for more insights at https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Dec. 10 at 2:29 AM
$PFE not thinking it was a great move with this China deal given all the negative views of CCCP relationships. Also it seems very odd to me to just complete the merger deal for company that has a weight loss product under development (injection) and pursue another weight loss product under development (pill) after just failing at their own weight loss product efforts - something seems a little tough to swallow in all of this or is it just me?
1 · Reply
TradeSwinger
TradeSwinger Dec. 10 at 1:21 AM
0 · Reply
taxplanr
taxplanr Dec. 10 at 1:16 AM
$BNTX $MRNA $PFE help get the child killer revoked https://childrenshealthdefense.org/defender/chd-asks-fda-to-revoke-covid-vaccine-licenses-petition/?utm_source=cc&utm_medium=email&utm_campaign=defender&utm_id=20251209
0 · Reply
scor0328
scor0328 Dec. 10 at 12:51 AM
$PFE 6 years ago we anxiously waited for this company and $MRNA to come up w/a vax and end the extremely high death toll we were experiencing. These efforts were funded and wholeheartedly supported by the government and its pandemic weary citizens. Once these companies came through for us, we rushed to make appointments for that first vax. Now the headline grabbing / attention deprived leaders of the FDA are figuring out how they can go after these companies. What short memories we all have. Major disincentive for the next pandemic.
3 · Reply
Turbofueled
Turbofueled Dec. 9 at 11:38 PM
$LEXX $LEXX is going to be the make it or break it for these Big Pharmas pill form…… Better come to the table things are gonna explode at $LEXX 🌋🌋 “As is typical for the GLP-1 drug class, the most frequent adverse events were gastrointestinal -- nausea and vomiting being the two most common side effects during the titration phase.” $GPCR $NVO $LLY $PFE https://www.techtarget.com/pharmalifesciences/news/366636177/Structure-announces-mid-phase-data-for-its-oral-GLP-1-candidate
1 · Reply
Latest News on PFE
Down 50%, Should You Buy the Dip on Pfizer?

Dec 9, 2025, 4:15 PM EST - 10 hours ago

Down 50%, Should You Buy the Dip on Pfizer?


Pfizer partners with YaoPharma for weight management treatment

Dec 9, 2025, 6:38 AM EST - 20 hours ago

Pfizer partners with YaoPharma for weight management treatment


Do These 3 Healthcare Stocks Need a Checkup?

Dec 5, 2025, 4:05 PM EST - 4 days ago

Do These 3 Healthcare Stocks Need a Checkup?

BMY MRK


2 Headwinds Facing Pfizer Stock Going Into 2026

Dec 5, 2025, 10:05 AM EST - 4 days ago

2 Headwinds Facing Pfizer Stock Going Into 2026


Pfizer: The Market Is Still Wrong About It

Dec 5, 2025, 9:00 AM EST - 4 days ago

Pfizer: The Market Is Still Wrong About It


2 Top Dividend Stocks to Buy Now and Hold For a Decade

Dec 2, 2025, 7:44 AM EST - 7 days ago

2 Top Dividend Stocks to Buy Now and Hold For a Decade

ABBV


This 7% Yielder Could Be a Top AI Play

Nov 30, 2025, 4:04 PM EST - 9 days ago

This 7% Yielder Could Be a Top AI Play


8 Dividend Stocks Every Investor Should Consider

Nov 28, 2025, 5:30 AM EST - 11 days ago

8 Dividend Stocks Every Investor Should Consider

ABBV AXP COST JPM NVDA PM SPGI


Final Trade: DAL, AXP, PFE, HMY

Nov 26, 2025, 6:20 PM EST - 13 days ago

Final Trade: DAL, AXP, PFE, HMY

AXP DAL HMY


Did Pfizer Just Say "Checkmate" to Novo Nordisk?

Nov 26, 2025, 4:15 AM EST - 13 days ago

Did Pfizer Just Say "Checkmate" to Novo Nordisk?


Is This the Best Value Stock to Buy While Markets Are Volatile?

Nov 25, 2025, 6:24 AM EST - 14 days ago

Is This the Best Value Stock to Buy While Markets Are Volatile?


Pfizer Crosses Below Key Moving Average Level

Nov 20, 2025, 4:05 PM EST - 19 days ago

Pfizer Crosses Below Key Moving Average Level


Is Pfizer's 6.9%-Yielding Dividend Still Safe?

Nov 20, 2025, 9:30 AM EST - 19 days ago

Is Pfizer's 6.9%-Yielding Dividend Still Safe?


Pfizer: Is This Pharma Giant Finally A Bargain

Nov 19, 2025, 3:51 PM EST - 20 days ago

Pfizer: Is This Pharma Giant Finally A Bargain


Pfizer in $41.5 million settlement with Texas over ADHD drug

Nov 19, 2025, 10:31 AM EST - 20 days ago

Pfizer in $41.5 million settlement with Texas over ADHD drug


2 No-Brainer Healthcare Stocks to Buy Now

Nov 18, 2025, 6:45 AM EST - 21 days ago

2 No-Brainer Healthcare Stocks to Buy Now

VKTX


Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?

Nov 17, 2025, 9:10 PM EST - 22 days ago

Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?


2 Giant Healthcare Stocks to Buy Hand Over Fist in November

Nov 17, 2025, 10:00 AM EST - 22 days ago

2 Giant Healthcare Stocks to Buy Hand Over Fist in November

MDT


Down 55%, Should You Buy the Dip on Pfizer?

Nov 17, 2025, 4:35 AM EST - 22 days ago

Down 55%, Should You Buy the Dip on Pfizer?


Tiger65
Tiger65 Dec. 10 at 5:08 AM
$PFE in COVID times this company’s drug was bought by the government and the mandate to be vaccinated has been issued by the government and administration of the USA. That‘s why this news is not eaten so hot as it has been cooked.
0 · Reply
AlertsAndNews
AlertsAndNews Dec. 10 at 4:13 AM
$MRNA $PFE $BNTX FDA Probes Potential Links Between Covid-19 Vaccines and Adult Deaths – Bloomberg The FDA has opened an investigation into whether Covid-19 vaccines may be connected to deaths in adults, federal health officials said. An HHS spokesperson noted the agency is reviewing cases across multiple age groups as part of a broader safety assessment.
0 · Reply
grocklein
grocklein Dec. 10 at 4:10 AM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 10 at 3:28 AM
Enter: $PFE Calls Strike Price: $26 Expiry Date: JAN 02 2026 Buy in Price: $0.45 - $0.45 Sell Price: $0.68 Profit : +52% (Turn every $1 into $1.52) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 2:37 AM
Actionable Trade Alert for $PFE: Market Context: $PFE is currently trading at $25.36, with an RSI of 49.06 indicating a neutral momentum. The stock is positioned between its 60D high of $27.69 and low of $23.58, suggesting potential for upward movement. Directional Bias: The price is above the 30-day moving average (MA30) of $25.11 and the 50-day moving average (MA50) of $25.19, indicating a bullish sentiment. The ATR of 0.59 suggests moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $25.40 - Stop Loss: $24.80 (approximately 2.4% risk) - Take Profit Targets: 1. $26.00 (2.35% gain) 2. $26.75 (5.43% gain) 3. $29.75 (17.45% gain) With this plan, we aim for a minimum ROI of 17% on the third target while maintaining a manageable risk. Stay informed for more insights at https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Dec. 10 at 2:29 AM
$PFE not thinking it was a great move with this China deal given all the negative views of CCCP relationships. Also it seems very odd to me to just complete the merger deal for company that has a weight loss product under development (injection) and pursue another weight loss product under development (pill) after just failing at their own weight loss product efforts - something seems a little tough to swallow in all of this or is it just me?
1 · Reply
TradeSwinger
TradeSwinger Dec. 10 at 1:21 AM
0 · Reply
taxplanr
taxplanr Dec. 10 at 1:16 AM
$BNTX $MRNA $PFE help get the child killer revoked https://childrenshealthdefense.org/defender/chd-asks-fda-to-revoke-covid-vaccine-licenses-petition/?utm_source=cc&utm_medium=email&utm_campaign=defender&utm_id=20251209
0 · Reply
scor0328
scor0328 Dec. 10 at 12:51 AM
$PFE 6 years ago we anxiously waited for this company and $MRNA to come up w/a vax and end the extremely high death toll we were experiencing. These efforts were funded and wholeheartedly supported by the government and its pandemic weary citizens. Once these companies came through for us, we rushed to make appointments for that first vax. Now the headline grabbing / attention deprived leaders of the FDA are figuring out how they can go after these companies. What short memories we all have. Major disincentive for the next pandemic.
3 · Reply
Turbofueled
Turbofueled Dec. 9 at 11:38 PM
$LEXX $LEXX is going to be the make it or break it for these Big Pharmas pill form…… Better come to the table things are gonna explode at $LEXX 🌋🌋 “As is typical for the GLP-1 drug class, the most frequent adverse events were gastrointestinal -- nausea and vomiting being the two most common side effects during the titration phase.” $GPCR $NVO $LLY $PFE https://www.techtarget.com/pharmalifesciences/news/366636177/Structure-announces-mid-phase-data-for-its-oral-GLP-1-candidate
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 9 at 11:04 PM
0 · Reply
hegdaom
hegdaom Dec. 9 at 9:47 PM
0 · Reply
scor0328
scor0328 Dec. 9 at 9:34 PM
$CAPR $PFE seems so desperate to buy growth, paying up and throwing darts at GLP 1 market. Buy the time they enter, the GLPs will be a commodity. Meanwhile you would think Bourla would be knocking on the door in San Diego for a P3 proven dmd treatment, esp after their failures.
3 · Reply
LeftyT
LeftyT Dec. 9 at 9:19 PM
$ALT Competition update: Pfizer $PFE is being penny wise and pound foolish w/ their Yao Pharma licensing deal. It's a $1.9 B biobucks deal w/ $150 M cash up front, which was critical as Yao didn't have enough cash to finish their ongoing P1 trial. All that for another GLP-1 agonist, all that because they're too cheap to buy out ALT for $4 b and get a P3 ready product. This is on top of their recent purchase of Metsera, after a bidding war w/ Novo Nordisk $NVO , to get yet another GLP-1 drug still in P2b testing. Not sure who's calling the shots on this at Pfizer, but the shotgun accuracy is costing them more than it should. https://www.fiercebiotech.com/biotech/pfizer-continues-renewed-obesity-push-2b-pact-fosun-units-glp-1-drug
2 · Reply
HedgeAlerts
HedgeAlerts Dec. 9 at 9:14 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PFE $25.50 Put · DEC 19, 2025 Exp Entry Price: $0.46 - $0.47 Exit Price Target: $0.64 Profit Margin: +40% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Willieberich
Willieberich Dec. 9 at 9:12 PM
$PFE I'm being forced to buy here again..10,000 is coming quickly..
0 · Reply
SeriouslyWhy
SeriouslyWhy Dec. 9 at 9:11 PM
$PFE wow what a pos
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Dec. 9 at 9:06 PM
$PFE Well the good news is the market closed on time
1 · Reply
10dollarput
10dollarput Dec. 9 at 9:05 PM
$PFE This guy fucked us by selling today.
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Dec. 9 at 9:03 PM
$PFE - Well, it was a shitty day for pharma in general, so…
0 · Reply
MHM7700
MHM7700 Dec. 9 at 9:00 PM
70% gains locked in on the $PFE puts. https://stocktwits.com/MHM7700/message/638534782
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 9 at 9:00 PM
$PFE -3% from pre market high, genuinely fuck this stock
0 · Reply